Nitrofurantoin 50mg Tablet Franchise in Ahmedabad

UTI & Antibacterial Therapy Supplier in Mumbai

Niftafly 50 Tablet Distributor in Delhi

Urinary Infection Treatment Tablet Franchise Opportunity in Bangalore

Antibiotic Therapy Tablet Stockist in Hyderabad
Nitrofurantoin 50mg Export & Manufacturing in Chandigarh

Home/Products /nitrofurantoin-50mg-tablet

Niftafly 50 Tablet

Composition : Nitrofurantoin (50mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Niftafly 50 Tablet contains Nitrofurantoin 50mg, an antibacterial agent widely used for the treatment and prophylaxis of urinary tract infections caused by susceptible pathogens. It helps relieve common UTI symptoms such as burning micturition, frequent urination, and lower abdominal discomfort.

Nitrofurantoin works by inhibiting bacterial enzymes and disrupting cell wall synthesis, effectively preventing bacterial growth. Its standard formulation ensures effective therapy for mild to moderate urinary infections.

For distributors and healthcare suppliers, Niftafly 50 Tablet is a high-demand urinary tract therapy product, commonly used in hospitals, clinics, and pharmacies. The widespread prevalence of UTIs ensures steady and continuous market demand.

Adding Niftafly 50 Tablet to your antibacterial and UTI therapy segment creates strong opportunities in pharmacies, hospitals, urology clinics, export markets, and third-party manufacturing. Its proven efficacy, reliable performance, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Niftafly 50 Tablet contains Nitrofurantoin 50mg, an antibacterial agent widely used for the treatment and prophylaxis of urinary tract infections caused by susceptible pathogens. It helps relieve common UTI symptoms such as burning micturition, frequent urination, and lower abdominal discomfort.

Nitrofurantoin works by inhibiting bacterial enzymes and disrupting cell wall synthesis, effectively preventing bacterial growth. Its standard formulation ensures effective therapy for mild to moderate urinary infections.

For distributors and healthcare suppliers, Niftafly 50 Tablet is a high-demand urinary tract therapy product, commonly used in hospitals, clinics, and pharmacies. The widespread prevalence of UTIs ensures steady and continuous market demand.

Adding Niftafly 50 Tablet to your antibacterial and UTI therapy segment creates strong opportunities in pharmacies, hospitals, urology clinics, export markets, and third-party manufacturing. Its proven efficacy, reliable performance, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, loss of appetite, or mild gastrointestinal discomfort. Rare but serious side effects can include liver toxicity, pulmonary reactions, peripheral neuropathy, or allergic reactions. Patients should seek medical advice if severe or persistent symptoms occur.

Niftafly 50 Tablet is indicated for the treatment and prevention of uncomplicated urinary tract infections caused by susceptible bacteria. It is also suitable for long-term prophylactic use in patients with recurrent UTIs, as prescribed by a healthcare professional.

Niftafly 50 Tablet should be taken exactly as prescribed, preferably with food or milk to reduce gastrointestinal irritation. Patients with impaired kidney function, liver disease, or a known allergy to Nitrofurantoin should inform their doctor before use. Adequate hydration is recommended to support urinary clearance.

Store Niftafly 50 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use the tablet beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation